Valuation
52-Week Range
60.45 - 139.00
Annual income statement
#
Abivax SA annual revenue, operating income and net income in EUR, 2014 to 2024. Revenue was 10.8m in 2024.
| Year |
Revenue (EUR) |
Operating income |
Net income |
Net margin |
| 2024 |
10.8m |
-185.4m |
-176.2m |
|
| 2023 |
4.6m |
-127.4m |
-147.7m |
|
| 2022 |
4.6m |
-64.8m |
-60.7m |
|
| 2021 |
37,000 |
-52.2m |
-42.5m |
|
| 2020 |
14,000 |
-39.6m |
-37.6m |
|
| 2018 |
815,000 |
-19.1m |
-15.8m |
|
| 2017 |
356,000 |
-14.2m |
-11.2m |
|
| 2016 |
151,000 |
-18.2m |
-14.3m |
|
| 2015 |
228,000 |
-18.3m |
-16.0m |
|
| 2014 |
67,134 |
-5.1m |
-5.1m |
|
Current: 5.12% 路
30d ago: 4.85% 路
All-time high: 6.66% (2026-06-19)
| Date |
Type |
Details |
Price |
Amount |
|